Development of CAR-T Cell Therapies for Multiple Myeloma

0
26
Main challenges to CAR-T cell therapy will be highlighted as well as strategies to structurally improve the CAR-T cell product, and thereby its efficacy and safety.
[Leukemia]
Abstract